Status:
TERMINATED
Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated for Leukemia (ONCOPED SAPATIC)
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
mooven society
Conditions:
Leukemia
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
Leukemia is the most common form of cancer (29%) in children, adolescents, and young adults (AYA) (CNIB Report, 2017). Current treatments for leukemia (conventional chemotherapy or hematopoietic stem ...
Detailed Description
Leukemia is the most common form of cancer (29%) in children, adolescents, and young adults (AYA). Current treatments for leukemia (conventional chemotherapy or hematopoietic stem cell transplantation...
Eligibility Criteria
Inclusion
- Patient with Leukemia and followed in intensive post-treatment or with lymphoma and followed in post autologous graft, patient aged 12 to 25 years old (child/AYA), included in the CHU Montpellier and identified by the mobile support team AYA Occitanie-Est, and or the Occitanie-Est Pediatric Division of the Oncology Network of the Occitanie Region,
- Having completed and signed a consent form for the study (Signature of consent by the parents if the patient is a minor)
- affiliated to a safety social regime
Exclusion
- Contraindication to the practice of an APA program.
Key Trial Info
Start Date :
December 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 6 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04136665
Start Date
December 14 2019
End Date
September 6 2022
Last Update
December 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Montpellier
Montpellier, France, 34295